DICE Therapeutics to Present at Upcoming Investor Conferences
November 03, 2022 at 16:05 PM EDT
SOUTH SAN FRANCISCO, Calif., Nov. 03, 2022 (GLOBE NEWSWIRE) -- DICE Therapeutics, Inc. (Nasdaq: DICE), a biopharmaceutical company leveraging its proprietary technology platform to build a pipeline of novel oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas, today announced that management will present at the following investor conferences:
Live and archived webcasts of the presentations will be accessible under “News & Events” in the Investors section of the company's website for 90 days after the applicable event.
About DICE Therapeutics, Inc.